It is valuable for pharmacists to understand exactly how price transparency data are sourced, what information can be found, antitrust concerns, and implications for the pharmaceutical industry.
AJPB® The American Journal of Pharmacy Benefits® November 2024
Formularies have become one of the biggest barriers to realizing the cost-saving potential of biosimilars.
Shifting from a vertical, isolated care model into a collaborative approach can improve the clinician and patient experience.
Three of the largest pharmacy benefit managers ––Express Scripts, Optum, and Caremark––are listed in the suit.
The request comes as increased scrutiny is levied toward pharmacy benefit managers for alleged unfair business practices.
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety
3
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
4
Effectively Managing Immunizations in the Long-Term Care Setting
5
